Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life  Pekka Pinola, Ph.D., Katri Puukka,

Slides:



Advertisements
Similar presentations
Clinically significant and sustained weight loss is achievable in obese women with polycystic ovary syndrome followed in a regular medical practice  Lysanne.
Advertisements

Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M
Efficacy of predictive models for polycystic ovary syndrome using serum levels of two antimüllerian hormone isoforms (proAMH and AMHN,C)  Michael W. Pankhurst,
Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome  Anuja Dokras, M.D., Ph.D., Shailly Saini,
Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis  Anuja Dokras, M.D., Ph.D., Shari.
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis  Héctor F. Escobar-Morreale, M.D., Ph.D., Manuel Luque-Ramírez,
Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome  Elisabeth Lerchbaum,
Comparison of hormonal and metabolic markers after a high-fat, Western meal versus a low-fat, high-fiber meal in women with polycystic ovary syndrome 
Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women  Babak Mokhlesi, M.D.,
Kalliopi Kotsa, M. D. , Ph. D. , Maria P. Yavropoulou, M. D
Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters  Enrico Carmina, M.D., Francesco.
Effect of a very-low-calorie diet on in vitro fertilization outcomes
Ramifications of adolescent menstrual cycles ≥42 days in young adults
Antimüllerian hormone levels decrease in women using combined contraception independently of administration route  Sanna Kallio, M.D., Johanna Puurunen,
Dennis J. Hand, Ph. D. , Vanessa L. Short, Ph. D. , M. P. H. , Diane J
Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome  Anuja Dokras, M.D., Ph.D., Shailly Saini,
Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study  Cem Celik, M.D., Nicel.
Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome 
Insulin resistance in oligomenorrheic infertile women with non-polycystic ovary syndrome  Shirei Ohgi, M.D., Koji Nakagawa, M.D., Ph.D., Rieko Kojima,
Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study  Angela Kerchner, B.A., Whitney Lester,
Robert A. Wild, M. D. , Manfredi Rizzo, M. D. , Sheri Clifton, Ph. D
Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women.
Rebecca A. Feldman, M. D. , Kathleen O'Neill, M. D. , Samantha F
Predictive factors of health-related quality of life in patients with polycystic ovary syndrome: a structural equation modeling approach  Fatemeh Bazarganipour,
A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome  Dorte Glintborg, M.D., Ph.D.,
Evolutionary determinants of polycystic ovary syndrome: part 1
Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis 
Epidemiology and Adverse Cardiovascular Disease (CVD) Risk Profile of Polycystic Ovarian Syndrome (PCOS): The Kaiser Permanente Polycystic Ovarian Syndrome.
Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens 
Pernille Fog Svendsen, M. D. , Michael Christiansen, M. D
The determinants of insulin sensitivity, β-cell function, and glucose tolerance are different in patients with polycystic ovary syndrome than in women.
Mieke Carine Wim Eeckhaut, Ph.D.  Fertility and Sterility 
Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk  Molly M. Quinn, M.D., Chia-Ning Kao,
Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular.
Circulating antimüllerian hormone and steroid hormone levels remain high in pregnant women with polycystic ovary syndrome at term  Terhi T. Piltonen,
The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study  Gwinnett Ladson, M.D., William C. Dodson,
Andrew C. Bjonnes, M.S., Richa Saxena, Ph.D., Corrine K. Welt, M.D. 
Hyperglycemia Stimulates Activation of Nuclear Factor κB (NFκB) in Mononuclear Cells (MNC) of Women With Polycystic Ovary Syndrome (PCOS)  F. Gonzalez,
Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome  Macarena Alpañés, M.D., Manuel.
Ovulation induction in women with polycystic ovary syndrome
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 caucasian premenopausal women with hirsutism as the referral diagnosis  Dorte.
Prevalence of polycystic ovary syndrome in Chinese obese women of reproductive age with or without metabolic syndrome  Peiwen Liang, M.D., Liuqing Xi,
Increased secretion of amylin in women with polycystic ovary syndrome
Prevalence of polycystic ovary syndrome in adolescents
Fleur R. Cattrall, M. B. B. S. , Beverley J. Vollenhoven, M. B. B. S
Antoni J. Duleba, M.D., Ibrahim M. Ahmed, M.D.  Fertility and Sterility 
Comparison of two doses of metformin (2. 5 and 1
Metformin reduces serum müllerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment  Richard Fleming, Ph.D.,
Banu Ucar, M. D. , Volkan Noyan, M. D. , Osman Caglayan, M. D
Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial  Antoni J. Duleba, M.D.,
Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal women  Hong Zang, M.D., Kjell Carlström,
Impact of laparoscopic ovarian drilling on anti-Müllerian hormone levels and ovarian stromal blood flow using three-dimensional power Doppler in women.
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Manuel Maliqueo, Ph. D. , Bárbara Echiburú, Ph. D
Paolo Moghetti, M.D.  Fertility and Sterility 
Are patients with idiopathic hirsutism (IH) insulin resistant
Rupal Shroff, B. S. , Craig H. Syrop, M. D. , William Davis, M. D
Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions  Kristen Farrell, M.S.,
Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome  Yuwen Wu, M.D., Jianhua Zhang,
Proteomic biomarkers for ovarian cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration  Nicolas.
Current evaluation of amenorrhea
Tsan-Hon Liou, M. D. , Ph. D. , Jen-Hung Yang, M. D. , Ph. D
Clinical and laboratory characteristics of adolescents with both polycystic ovary disease and anorexia nervosa  Orit Pinhas-Hamiel, M.D., Nurit Pilpel,
Adiponectin levels reflect the different phenotypes of polycystic ovary syndrome: study in normal weight, normoinsulinemic patients  Artemis Karkanaki,
Decrease in adiponectin levels in women with polycystic ovary syndrome after an oral glucose tolerance test  Dimitrios Panidis, M.D., Ph.D., Dimitrios.
Hyperinsulinemia and circulating dehydroepiandrosterone sulfate in white and Mexican American women with polycystic ovary syndrome  Robert P. Kauffman,
Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels 
Diabetes mellitus and insulin resistance in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis 
Low body mass index compromises live birth rate in fresh transfer in vitro fertilization cycles: a retrospective study in a Chinese population  Jiali.
Presentation transcript:

Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life  Pekka Pinola, Ph.D., Katri Puukka, Ph.D., Terhi T. Piltonen, Ph.D., Johanna Puurunen, Ph.D., Eszter Vanky, Ph.D., Inger Sundström- Poromaa, Ph.D., Elisabet Stener-Victorin, Ph.D., Angelica Lindén Hirschberg, Ph.D., Pernille Ravn, Ph.D., Marianne Skovsager Andersen, Ph.D., Dorte Glintborg, Ph.D., Jan Roar Mellembakken, Ph.D., Aimo Ruokonen, Ph.D., Juha S. Tapanainen, Ph.D., Laure C. Morin-Papunen, Ph.D.  Fertility and Sterility  Volume 107, Issue 3, Pages 788-795.e2 (March 2017) DOI: 10.1016/j.fertnstert.2016.12.017 Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Body mass indices, waist circumferences, and parameters of glucose metabolism at different ages in the study populations. The bars represent means and the error bars standard deviations. Results are adjusted for body mass index. PCOS = polycystic ovary syndrome. Fertility and Sterility 2017 107, 788-795.e2DOI: (10.1016/j.fertnstert.2016.12.017) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Lipids at different ages in the study populations. The bars represent the means and the error bars the standard deviations. Results are adjusted for body mass index. PCOS = polycystic ovary syndrome. Fertility and Sterility 2017 107, 788-795.e2DOI: (10.1016/j.fertnstert.2016.12.017) Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions